|
[1]
|
Therapeutic Potential of Aptamer–Protein Interactions
ACS Pharmacology & Translational Science,
2022
DOI:10.1021/acsptsci.2c00156
|
|
|
|
|
[2]
|
Therapeutic Potential of Aptamer–Protein Interactions
ACS Pharmacology & Translational Science,
2022
DOI:10.1021/acsptsci.2c00156
|
|
|
|
|
[3]
|
Integrating DNA Nanotechnology with Aptamers for Biological and Biomedical Applications
Matter,
2021
DOI:10.1016/j.matt.2020.11.002
|
|
|
|
|
[4]
|
Potential applications of aptamers in veterinary science
Veterinary Research,
2021
DOI:10.1186/s13567-021-00948-4
|
|
|
|
|
[5]
|
Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases
International Journal of Molecular Sciences,
2020
DOI:10.3390/ijms21093252
|
|
|
|
|
[6]
|
Nucleic Acids as Gene Anticancer Drug Delivery Therapy
2019
DOI:10.1016/B978-0-12-819777-6.00020-2
|
|
|
|
|
[7]
|
Targeted drug delivery for tumor therapy inside the bone marrow
Biomaterials,
2018
DOI:10.1016/j.biomaterials.2017.11.029
|
|
|
|
|
[8]
|
Immunocytochemistry Based on a Cell-Type-Specific Aptamer for Rapid Immunostaining of Adenocarcinoma Cells in Clinical Serosal Fluids
Pathology & Oncology Research,
2018
DOI:10.1007/s12253-018-0555-9
|
|
|
|
|
[9]
|
DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow Involvement
Molecular Pharmaceutics,
2018
DOI:10.1021/acs.molpharmaceut.7b01169
|
|
|
|
|
[10]
|
DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow Involvement
Molecular Pharmaceutics,
2018
DOI:10.1021/acs.molpharmaceut.7b01169
|
|
|
|
|
[11]
|
Selection and targeting of EpCAM protein by ssDNA aptamer
PLOS ONE,
2017
DOI:10.1371/journal.pone.0189558
|
|
|
|
|
[12]
|
Cell-targeting aptamers act as intracellular delivery vehicles
Applied Microbiology and Biotechnology,
2016
DOI:10.1007/s00253-016-7686-2
|
|
|
|
|
[13]
|
Aptamers
2016
DOI:10.1201/b20047-9
|
|
|
|
|
[14]
|
Therapeutic nucleic acids: current clinical status
British Journal of Clinical Pharmacology,
2016
DOI:10.1111/bcp.12987
|
|
|
|
|
[15]
|
Ex Vivo and In Vivo Imaging and Biodistribution of Aptamers Targeting the Human Matrix MetalloProtease-9 in Melanomas
PLOS ONE,
2016
DOI:10.1371/journal.pone.0149387
|
|
|
|
|
[16]
|
Therapeutic nucleic acids: current clinical status
British Journal of Clinical Pharmacology,
2016
DOI:10.1111/bcp.12987
|
|
|
|
|
[17]
|
Molecular Dynamics Simulation Analysis of Anti-MUC1 Aptamer and Mucin 1 Peptide Binding
The Journal of Physical Chemistry B,
2015
DOI:10.1021/acs.jpcb.5b02483
|
|
|
|
|
[18]
|
Applications of aptamers for chemistry analysis, medicine and food security
Science China Chemistry,
2015
DOI:10.1007/s11426-015-5344-7
|
|
|
|
|
[19]
|
Identification of Epithelial Ovarian Tumor-Specific Aptamers
Nucleic Acid Therapeutics,
2015
DOI:10.1089/nat.2014.0522
|
|
|
|
|
[20]
|
Aptamer-Functionalized Nanoparticles as “Smart Bombs”: The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment
Targeted Oncology,
2015
DOI:10.1007/s11523-015-0371-z
|
|
|
|
|
[21]
|
Therapeutic aptamers: developmental potential as anticancer drugs
BMB Reports,
2015
DOI:10.5483/BMBRep.2015.48.4.277
|
|
|
|
|
[22]
|
Molecular Dynamics Simulation Analysis of Anti-MUC1 Aptamer and Mucin 1 Peptide Binding
The Journal of Physical Chemistry B,
2015
DOI:10.1021/acs.jpcb.5b02483
|
|
|
|
|
[23]
|
Chemical Biology of Nucleic Acids
2014
DOI:10.1007/978-3-642-54452-1_24
|
|
|
|
|
[24]
|
Chemical Biology of Nucleic Acids
2014
DOI:10.1007/978-3-642-54452-1_24
|
|
|
|
|
[25]
|
Chemical Biology of Nucleic Acids
RNA Technologies,
2014
DOI:10.1007/978-3-642-54452-1_24
|
|
|
|